Morgan Stanley 13D and 13G filings for ProKidney Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-07 11:36 am Sale | 2025-06-30 | 13G | ProKidney Corp. PROK | MORGAN STANLEY MS | 5,712,128 4.400% | -4,346,796 (-43.21%) | Filing |
| 2025-05-06 3:45 pm Sale | 2025-03-31 | 13G | ProKidney Corp. PROK | MORGAN STANLEY MS | 10,058,924 7.800% | -3,872,102 (-27.79%) | Filing |
| 2024-11-08 10:13 am Purchase | 2024-09-30 | 13G | ProKidney Corp. PROK | MORGAN STANLEY MS | 13,931,026 11.100% | 3,155,356 (+29.28%) | Filing |
| 2024-02-09 2:56 pm Sale | 2023-12-31 | 13G | ProKidney Corp. PROK | MORGAN STANLEY MS | 10,775,670 16.100% | -158,512 (-1.45%) | Filing |
| 2023-02-10 2:08 pm Purchase | 2022-12-30 | 13G | ProKidney Corp. PROK | MORGAN STANLEY MS | 10,934,182 17.800% | 934,182 (+9.34%) | Filing |
| 2022-09-12 5:17 pm Purchase | 2022-08-31 | 13G | ProKidney Corp. PROK | MORGAN STANLEY MS | 10,000,000 16.200% | 10,000,000 (New Position) | Filing |